Is ROSG a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

1,174 people get ROSG articles and Market Currents by email alert.

Get email alerts on ROSG »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Why I Think Rosetta Genomics Will See $20 In 1-2 Years
Carl Cachia • Wed, Nov 21, 2012 • 25 Comments
Why Rosetta Genomics Is Deeply Undervalued
Joseph Morsi • Thu, Sep 6, 2012 • 28 Comments
Rosetta Genomics: What Happens When The Music Ends?
Adam Sans • Tue, May 29, 2012 • 20 Comments
The Rosetta Genomics Roller Coaster Ride
Bryce Istvan • Tue, May 29, 2012 • 4 Comments
Rosetta Genomics: Mining Genes From Junk (Part I)
Ohad Hammer • Mon, Jan 28, 2008 • 1 Comment
Investing in Rosetta Genomics Means Investing in MiRNAs
Brian Orelli • Mon, Apr 23, 2007 • 1 Comment
Rosetta Genomics Has More Partners Than Products
Brian Orelli • Mon, Apr 16, 2007
Can Biotechs Make Any Money From MiRNAs?
Brian Orelli • Tue, Apr 10, 2007
Rosetta Genomics: Can This Dream Team Woo Wall Street?
Shlomo Greenberg • Thu, Apr 5, 2007

To learn more about Seeking Alpha Pro, click here.

Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Mon, Nov 26, 2012 • 1 Comment
Biotech Weekend Recap: Short Week, Major Rally
Brian L. Wilson • Sun, Nov 25, 2012 • 10 Comments
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Wed, Nov 7, 2012 • 3 Comments
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Tue, Sep 18, 2012
3 Stocks To Consider In Molecular Diagnostics
Mel Daris • Tue, Sep 4, 2012 • 5 Comments
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Mon, Aug 27, 2012 • 7 Comments
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Fri, Aug 24, 2012 • 8 Comments
All Eyes On Jobs - Hot Stocks In The News
Markos Kaminis • Fri, Jul 6, 2012 • 1 Comment
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Tue, Jun 19, 2012 • 2 Comments
Which Mid-June Summer Biotech Romance Will Last?
Jessica King Holden • Mon, Jun 18, 2012 • 11 Comments
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Tue, May 29, 2012 • 1 Comment
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Fri, May 25, 2012 • 2 Comments
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Thu, May 24, 2012 • 1 Comment
3 Biotech Stocks On The Move
Jessica King Holden • Tue, May 22, 2012 • 2 Comments
Value Trap or Play? 12 Smallcaps Hitting New Lows
The Keating Letter • Thu, Jan 20, 2011 • 11 Comments
Biotech Merger/Acquisition Activity Mixed During Major Conference
Michael Becker • Tue, Jan 18, 2011 • 1 Comment
How Israeli IPOs Are Faring on Wall Street
Shlomi Cohen • Wed, Nov 17, 2010 • 5 Comments
Novartis Halts Development of Two Drugs: Biotech's Latest Tribulations
The Burrill Report • Mon, Oct 11, 2010
Rosetta Genomics: Giving Isis and Alnylam a Run for Their miRNAs?
Joseph Krueger • Thu, Apr 8, 2010 • 23 Comments
The Future of Biotech: Party Like It's 1999
Joseph Krueger • Sun, Jan 17, 2010 • 15 Comments

Rosetta Genomics' CEO Presents at 25th Annual ROTH Conference (Transcript)
Wed, Mar 20
Rosetta Genomics' CEO Hosts Business Update Conference (Transcript)
Tue, Oct 2, 2012 • 4 Comments
Rosetta Genomics Ltd. Q2 2008 Earnings Call Transcript
Tue, Aug 19, 2008

Medicare Administrator Issues Final Local Coverage Determination for Rosetta Cancer Origin Test™

PR Newswire (Thu, 12:30PM)
Rosetta Genomics Executes Credentialing Agreement with Three Rivers Provider Network

PR Newswire (Jun 7, 2013)
Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test Manuscript

PR Newswire (Jun 6, 2013)
Rosetta Genomics to Increase the Number of U.S. Sales Territories

PR Newswire (Jun 4, 2013)
Rosetta Genomics Announces Presence at ASCO 2013

PR Newswire (May 28, 2013)
Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

PR Newswire (May 22, 2013)
Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2

PR Newswire (May 20, 2013)
Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories

PR Newswire (May 10, 2013)
Rosetta Genomics microRNA-based Diagnostic Assays to be Showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting

PR Newswire (May 7, 2013)
Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories

PR Newswire (Apr 18, 2013)
Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013

PR Newswire (Apr 2, 2013)
Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology

PR Newswire (Apr 1, 2013)
Rosetta Genomics To Host Business Update Conference Call on April 10, 2013

PR Newswire (Mar 25, 2013)
Rosetta Genomics Receives 25th U.S. Patent Allowance

PR Newswire (Mar 18, 2013)
Rosetta Genomics to Present at the 25th Annual Roth Conference

PR Newswire (Mar 12, 2013)
Rosetta Genomics Receives Two Key U.S. Patent Allowances

PR Newswire (Feb 14, 2013)
Study Validating Ability of microRNAs to Predict Progression of Bladder Cancer Published in British Journal of Urology International

PR Newswire (Feb 7, 2013)
Rosetta Genomics to be Featured on The Balancing Act® Airing on Lifetime Television Network

PR Newswire (Jan 30, 2013)
Rosetta Genomics Reports Study Comparing microRNA Profiles of Cancer of Unknown Primary and Metastases of Known Primary Tumors Published in Clinical Experimental Metastasis

PR Newswire (Jan 9, 2013)
Rosetta Genomics to Present at Sidoti & Company 2013 Micro-Cap Conference

PR Newswire (Jan 4, 2013)

ROSG vs. ETF Alternatives

Company Description

Currently, there's no company description for ROSG.

Sector: Healthcare

Industry: Diagnostic Substances

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, June 13, 12:46 PM Rosetta Genomics (ROSG +8.3%) pops after Novitas Solutions, the designated Medicare Administrative Contractor for the company's microRNA-based diagnostic assays, rules that ROSG's microRNA assay is reasonable and necessary for providing an important niche in pathologic diagnoses of cancer. The final determination confirms continued Medicare coverage for ROSG's Cancer Origin Test. 1 Comment [Healthcare, On the Move]
Friday, June 7, 12:45 PM Midday top 10 gainers: OSH +23%. WSBF +19%. OPTT +17%. CSFS +14%. BDBD +13%. JKS +11%. ROSG +11%. THO +10%. ECTY +10%. KFS +9%.
Midday top 10 Losers: FSGI -56%. TIVO -17%. USM -17%. IRM -16%. ZQK -12%. JRCC -11%. LQDT -11%. AFFY -10%. CBPO -10%. TRUE -8%. Comment! [On the Move]
Friday, June 7, 12:23 PM Rosetta Genomics (ROSG +11.8%) jumps today after it announcing the execution of a credentialing agreement with Three Rivers Provider Network for the Rosetta Cancer Origin Test. Three Rivers is one of the largest supplemental PPO's in the U.S., providing healthcare benefits to more than 10M members nationwide. Comment! [Healthcare, On the Move]
Friday, June 7, 9:16 AM Shares of Rosetta Genomics (ROSG) soar 16% premarket after the company signs a credentialing agreement with Three Rivers Provider Network for the Rosetta Cancer Origin Test (miRview). This marks ROSG's second executed agreement with a U.S. PPO in the last three weeks (I, II). (PR) Comment! [Healthcare, On the Move]
Friday, June 7, 9:11 AM Premarket gainers: ROSG +16%. JKS +15%. IMUC +10%. NLST +8%. CBK +8%. GFA +7%. SNTA +7%. ELN +5%.
Losers: FSGI -42%. TIVO -18%. IRM -15%. JRCC -14%. LAMR -9%. CPRT -8%. FRO -7%. EQIX -8%. OIS -8%. Comment! [On the Move]
Thursday, June 6, 9:04 AM Rosetta Genomics (ROSG) jumps 10.6% premarket after saying the peer-reviewed journal Molecular Cancer, has accepted a manuscript outlining the ability of the company's miRview test (I, II) to accurately "identify the tumor of origin." In short, the test's predictions agreed with the final diagnosis in 92% of the 84 patients from which samples were taken. (PR) Comment! [Healthcare, On the Move]
Tuesday, June 4, 9:17 AM Rosetta Genomics (ROSG), which recently signed its first U.S. PPO agreement, rises 6.5% premarket after saying it is expanding its sales presence in the U.S. to 12 territories from five. The company also says its miRview test "has been trending positively for the past three months in terms of samples processed and samples billed." (PR) Comment! [Healthcare, On the Move]
Tuesday, May 21, 2:31 PM Shares of Rosetta Genomics (ROSG +2.4%) recovered from early losses to trade back near the prior day's highs after the company announced yesterday that it had signed a credentialing agreement with PPO provider Prime Health Services under which ROSG's miRview mets2 test will be included in Prime's covered products and services. Comment! [Healthcare, On the Move]
Monday, May 20, 9:26 AM Rosetta Genomics (ROSG) jumps 11.76% before the bell after executing a credentialing agreement with managed care company Prime Health Services under which the company's miRview mets2 test "will be included in Prime's covered products and services." The agreement is ROSG's first with a U.S. PPO. (PR) Comment! [On the Move]
Monday, May 20, 9:10 AM Premarket gainers: AQ +116%. MEAD +97%. PACT +38%. WBSN +28%. RSOL +26%. ROSG +16%. JASO +16%. JRCC +14%. QIHU +12%. LDK +9%. PXP +7%. IQNT +5%. VOYA +5%. DANG +5%.
Losers: XNPT -26%. NBG -8%. Comment! [On the Move]
Wednesday, May 15, 3:22 PM Gene-related stocks are getting a big bump today on the back of Angelina Jolie's recent decision to have a mastectomy to prevent possible breast cancer: Rosetta Genomics (ROSG +15.5%), Genetic Technologies (GENE +12.9%), Diagnocure (DGCRF.PK +12%), GeneNews (GNSWF.PK +5%). Myriad Genetics (MYGN -2.2%) is lower on a bout of profit-taking, possibly exacerbated by news of some insider selling today by its CEO as well. Comment! [Healthcare, On the Move]
Friday, May 10, 9:49 AM Rosetta Genomics (ROSG +0.6%) rises after saying it has received a $665K negotiated settlement payment from Sanra Labs in connection with ROSG's sale of Parkway Clinical Laboratories. (PR) Comment! [Healthcare, On the Move]
Thursday, April 18, 10:57 AM Rosetta Genomics (ROSG) drifts back to unchanged following a 5% pop in the pre-market after it announced a settlement agreement with Sanra Laboratories on the previous sale of Parkway Clinical Laboratories. Under the terms of the settlement, Sanra agrees to make a "best effort" to pay ROSG $625K, in addition to all sums previously paid by them according to the stock purchase agreement entered into in May 2009. Comment! [Healthcare]
Friday, April 12, 11:37 AM Rosetta Genomics (ROSG -3.6%) slips after Sidoti cut the shares to Neutral earlier today. The stock has essentially been dead money since last November, trading in a narrow range between $4 - $5 after cratering off a $23 higher earlier in the year. Just yesterday, Aegis cut its price target on the stock as well. On the surface, that may not seem too significant, but it's worth noting that Aegis has acted as the placement agent for the last four of ROSG’s public offerings. 1 Comment [Healthcare, On the Move]
Monday, April 1, 1:46 PM Rosetta Genomics (ROSG +4.8%) gets a lift today after saying earlier that a manuscript on the development and validation of the Company's microRNA-based diagnostic assay for the classification of renal cell tumors has been accepted for publication by Molecular Oncology. Comment! [Healthcare, On the Move]
Thursday, February 14, 9:10 AM Premarket gainers: ART +33%. ANGI +30%. STZ +29%. HNZ +20%. SKX +10%. ROSG +7%. Z +8%. ANR +7%. BUD +5%. EQIX +5%.
Losers: AFFY -22%. NSPH -20%. WTW -17%. CTL -17%. TRIP -10%. ULTA -9%. WFM -7%. BBRY -5%. ARR -6%. WIN -5%. 1 Comment [On the Move]

lazertron
What's going on with $ROSG? Any ideas?
Apr 16, 9:09 AM
Reply (2)

• !Report Abuse
View all 2 replies
gjajoa: Just gotta wait. Short term traders can really change the price.
Apr 17, 12:04 PM
• !Report Abuse
lazertron: Thanks, gjajoa
Apr 17, 6:38 PM
• !Report Abuse
Add a reply...

140 characters

Ryan Mallory
Morning Coffee, Day Trading Watchlist | $STX $DNKN $ROSG http://bit.ly/Xk08YC
Jan 9, 9:17 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

jsIRA
BIOF - Closed at 7.15, up 13% in down market. Only 5.18 million shares. Little buying will bring the stock move up big. The same for ROSG
10/13/12
Reply (7)

• !Report Abuse
View all 7 replies
sundate36: I'm also looking at MWW. Has gone up the past three days. I may be acquired, or at least the rumor may surface again. Undervalued, imho.
12/6/12
• !Report Abuse
jsIRA: It was down yestersay. but the near term trend is up. buy on dip will work and may see break out soon.
12/6/12
• !Report Abuse
Add a reply...

140 characters

A-1 "DUMB ACE"
Will ROSG have a stockholders meeting tomorrow or not. If so , will they report earnings?
10/10/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

jsIRA
ROSG - $5.81. it is in uptrend now with higher lows and higher highs. Buy on pull back.
10/8/12
Reply (17)

• !Report Abuse
View all 17 replies
sundate36: Mr. Shaw -- ROSG is at 5.20 again. Are you still with the trade or the market is getting too shaky?
10/22/12
• !Report Abuse
jsIRA: ROSG - I sold it at 5.64 last week and bought it back at 5.20 today.
10/22/12
• !Report Abuse
Add a reply...

140 characters

flyisu2002
$ROSG should get a nice short squeeze ahead of the conference on the 29th and the company update on oct 2nd. expecting good news
9/23/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

jsIRA
ROSG - bought at 5.22 and hope to see $6.00.
9/4/12
Reply (2)

• !Report Abuse
View all 2 replies
aumeoli: How about DANG now. $5.05?
9/5/12
• !Report Abuse
jsIRA: September is not a good month for DANG. October will see its run. But we bought it anyway as the stock will double in 6 months
9/5/12
• !Report Abuse
Add a reply...

140 characters

aumeoli
ROSG great call from J. Shaw at myIRAs.net
9/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

PPLLTT
I believe the support of ROSG should be around 4.5 or even lower. Keep shorting.
8/30/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Perkins Cove
ROSG sell @ 6.60 from pre mkt (today) entry of 5.40. +22%
8/23/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

lazertron
What's going on with $ROSG? Any ideas?
Apr 16, 9:09 AM
Reply (2)

• !Report Abuse
View all 2 replies
gjajoa: Just gotta wait. Short term traders can really change the price.
Apr 17, 12:04 PM
• !Report Abuse
lazertron: Thanks, gjajoa
Apr 17, 6:38 PM
• !Report Abuse
Add a reply...

140 characters

jsIRA
BIOF - Closed at 7.15, up 13% in down market. Only 5.18 million shares. Little buying will bring the stock move up big. The same for ROSG
10/13/12
Reply (7)

• !Report Abuse
View all 7 replies
sundate36: I'm also looking at MWW. Has gone up the past three days. I may be acquired, or at least the rumor may surface again. Undervalued, imho.
12/6/12
• !Report Abuse
jsIRA: It was down yestersay. but the near term trend is up. buy on dip will work and may see break out soon.
12/6/12
• !Report Abuse
Add a reply...

140 characters

jsIRA
ROSG - $5.81. it is in uptrend now with higher lows and higher highs. Buy on pull back.
10/8/12
Reply (17)

• !Report Abuse
View all 17 replies
sundate36: Mr. Shaw -- ROSG is at 5.20 again. Are you still with the trade or the market is getting too shaky?
10/22/12
• !Report Abuse
jsIRA: ROSG - I sold it at 5.64 last week and bought it back at 5.20 today.
10/22/12
• !Report Abuse
Add a reply...

140 characters

jsIRA
ROSG - bought at 5.22 and hope to see $6.00.
9/4/12
Reply (2)

• !Report Abuse
View all 2 replies
aumeoli: How about DANG now. $5.05?
9/5/12
• !Report Abuse
jsIRA: September is not a good month for DANG. October will see its run. But we bought it anyway as the stock will double in 6 months
9/5/12
• !Report Abuse
Add a reply...

140 characters

Perkins Cove
ROSG, "mad money" play....buy @ 5.40 pre mkt.
8/23/12
Reply (2)

• !Report Abuse
View all 2 replies
Perkins Cove: Now @ 5.85....let it ride...
8/23/12
• !Report Abuse
Ocean Man: Nice!
8/23/12
• !Report Abuse
Add a reply...

140 characters

Red Acre Investments
$ROSG "buy" rating from AGEIS after they diluted the stock 200% 2 weeks ago - can you say pump and dump?
8/23/12
Reply (4)

• !Report Abuse
View all 4 replies
Red Acre Investments: $ROSG - trader's delight - but investors beware - know the game and play accordingly if you choose.
8/23/12
• !Report Abuse
Perkins Cove: Exactly...!
8/23/12
• !Report Abuse
Add a reply...

140 characters

Ryan Mallory
4 Must Adds To Your Watchlist http://bit.ly/NxGIsB ROSG APOL STX VCLK
6/26/12
Reply (13)

• !Report Abuse
View all 13 replies
Ryan Mallory: wasn't the first time i was wrong on a stock and won't be the last one either. Time to move on buddy
8/11/12
• !Report Abuse
tooth doc: must add sounds pretty convincing, not a speculative type word. just watch your wording.
8/11/12
• !Report Abuse
Add a reply...

140 characters

ipower
when is the next earning annoucement for ROSG please?
6/25/12
Reply (1)

• !Report Abuse
View all 1 replies
tooth doc: earnings? i have more money in my pocket than rosetta has. they are taking panhandling to new levels.
8/3/12
• !Report Abuse
Add a reply...

140 characters

John Motyka
ROSG: I started w/ 3000 shares. Two Reverse Splits later I now Hold 50 shrs. Of course, ROSG moving to dilute w/ stock offering.so sad...jdm
5/26/12
Reply (9)

• !Report Abuse
View all 9 replies
John Motyka: Seems highly unlikely. Nice Pix young lady...bye...jdm
5/29/12
• !Report Abuse
Maria Auziliadora: thank you about the compliment but to me it just doesn't make sense sorry about your loss but that stock is complicated!!
5/29/12
• !Report Abuse
Add a reply...

140 characters

John Motyka
eabyrd: ROSG w/ Reverse Split 1:12. Price moves illussionary. Must move much farther to get me even. So sad...jdm
5/16/12
Reply (10)

• !Report Abuse
View all 10 replies
Ram B: Strong buys on OSIR!... Rosg still shooting but is now very over priced IMO; i believe it is now going to cool off. Look @ OSIR for moves
5/21/12
• !Report Abuse
iadops40: wow, amazing how ROSG skyrocketed 500% in 2 weeks...crazy
5/28/12
• !Report Abuse
Add a reply...

140 characters

ROSG Rosetta Genomics Ltd.

ROSG

Rosetta Genomics Ltd.